Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies by Richard S. Finn, Kangsheng Gu, Xi Chen, Philippe Merle, Kyung-Hun Lee, Mohamed Bouattour, Peiguo Cao, Wei Wang, Ann-Lii Cheng, Liangjun Zhu, Ho Yeong Lim, Masatoshi Kudo, Yueyin Pan, Ting-Tsung Chang, Julien Edeline, Wei Li, Ping Yang, Chen Li, Jianfeng Li, Abby B. Siegel, Shukui Qin

Subjects: “…Programmed cell death ligand 1…”
Get full text

Programmed cell death-ligand 1 expression in correlation with human papillomavirus status in cervical cancer: A 1-year retrospective study by Kaumudi Konkay, Padmavathi Devi Chaganti, Radhika Medidi, Ann Mary Varghese, Maruthi Devi Karri

Subjects: Get full text

Assessment of programmed cell death 1 and its programmed cell death ligand 1 levels in vitiligo by Hanan R. Nada, Ahmed Mourad, Laila A. Rashed, Ghada M. El-Hanafy, Nermeen M.A. Abdallah, Mohamed M. Abdelhady

Subjects: Get full text

Clinical factors associated with high PD‐L1 expression in patients with early‐stage non‐small cell lung cancer by Shuta Ohara, Kenichi Suda, Akira Hamada, Masato Chiba, Masaoki Ito, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Yasuhiro Tsutani

Subjects: Get full text

RIP2/NF-κB/PD-L1 signaling pathway is involved in temozolomide resistance by inducing autophagy in glioblastoma cells by Xiaomeng Liu, Xiaosong Liu, Lei Zhao, Jianliang Wu, Xiaoliang Wang, Yuhua Hu

Subjects: Get full text

Hepatoid adenocarcinoma of the stomach with ideal response to neoadjuvant chemo-immunotherapy: a case report by Linchuan Li, Linchuan Li, Dexu Zhang, Jiankang Zhu, Jiankang Zhu, Guangyong Zhang, Guangyong Zhang

Subjects: Get full text

PD-L1 on Circulating Tumor Cells Indicates Poor Prognosis in Breast Cancer by Xue-fei Wang, Guo-chao Zhang, Sha-fei Wu, Jia-xin Li, Qiang Sun

Subjects: Get full text

The efficacy of transarterial chemoembolization combined with helical iodine-125 seed implant, lenvatinib and PD-1 inhibitors in patients with hepatocellular carcinoma complicated... by Jia-Wen Lin, Jia-Wen Lin, Shen Zhang, Jian Shen, Yu Yin, Jun Yang, Cai-Fang Ni, Wan-Sheng Wang, Wan-Sheng Wang

Subjects: Get full text

Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression by Wei-Wen Sung, Chung-Hsing Chang

Subjects: “…programmed cell death-1/programmed cell death ligand-1…”
Get full text

Anti‐Angiogenic Agents for Advanced Hepatocellular Carcinoma Induce Liver Atrophy by Taijiro Wake, Tomoharu Yamada, Ryosuke Tateishi, Makoto Moriyama, Yuki Matsushita, Kazuya Okushin, Takuma Nakatsuka, Masaya Sato, Tatsuya Minami, Yotaro Kudo, Mitsuhiro Fujishiro

Subjects: “…anti‐programmed cell death ligand 1…”
Get full text

Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study by Parneet K. Cheema, Iqra Syed, Femida Gwadry-Sridhar, Muhammad Rakibuz-Zaman, Robin Sachdeva, Alec Pencz, Luna Zhan, Katrina Hueniken, Devalben Patel, Karmugi Balaratnam, Khaleeq Khan, Benjamin Grant, Brandon S. Sheffield, M. Elizabeth O. Locke, Daniel Moldaver, Mary Kate Shanahan, Geoffrey Liu, M. Sara Kuruvilla

Subjects: Get full text

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and ne... by Shiya Ji, Xupeng Chen, Yebo Yu, Qiuping Jia, Xingxing Zhang, Zixin Gao

Subjects: Get full text

The impact of vascular endothelial growth factor on oral squamous cell carcinoma through dendritic cell induction and facilitation of tumor immune tolerance by Peng Zhang, Yue Xu, Bolei Cai, Jiaqiang Xu, Tao Wang, Hongyan Xu

Subjects: “…Tumor microenvironment programmed cell death ligand 1…”
Get full text

Myomedin variants developed for in vitro PD-L1 diagnostics in tissue samples of non-small cell lung carcinoma patients by Hana Petroková, Joanna Maria Mierzwicka, Prosenjit Chakraborty, Leona Rašková Kafková, Jana Vaculová, Jozef Škarda, Ondřej Fischer, Petr Kosztyu, Milan Kuchař, Milan Raška, Petr Malý

Subjects: Get full text

Current trends in the immunotherapy of metastatic and recurrent squamous cell carcinoma of the head and neck by Yu. V. Kostalanova, K. A. Ganina, A. A. Makhonin, A. G. Gabrielyan

Subjects: Get full text

Development and Validation of a Biolayer Interferometry Method for Determination of Human Anti-PD-1 Monoclonal Antibody Concentration in Cynomolgus Serum by K. V. Ulyanova, A. A. Kazarov, M. S. Pantyushenko, A. A. Olenev, I. V. Lyagoskin, V. M. Simonov

Subjects: Get full text

Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin‐specific peptidase 9, X‐linked in oral squamous cell carcinoma by Wu Jingjing, Guo Wenzheng, Wen Donghua, Hou Guangyu, Zhou Aiping, Wu Wenjuan

Subjects: Get full text

Case Report: Long-term response control in a patient with metastatic gastric squamous cell carcinoma treated with nivolumab and chemoradiotherapy by Yu-ying Lei, Li Li, Ya-bin Shi, Xiao-hui Han, Yi-tong Li, Wen-jun Ren, Ai-xia Sui

Subjects: Get full text

A Multispecific Checkpoint Inhibitor Nanofitin with a Fast Tumor Accumulation Property and Anti-Tumor Activity in Immune Competent Mice by Perrine Jacquot, Javier Muñoz-Garcia, Antoine Léger, Antoine Babuty, Manon Taupin, Laurie Fradet, Fabio Dupont, Marie-Françoise Heymann, Mathieu Cinier, Dominique Heymann

Subjects: Get full text

PD-L1 expression predicts the efficacy of PD-1 blockade plus chemotherapy versus chemotherapy alone in treatment-naïve advanced or metastatic gastric cancer: a pooled analysis of r... by Wei Zhou, Zeng-Zhi Cai, Zhuolin Fan, Xu Zheng, Yu-Tong Chen

Subjects: Get full text